A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants
Clinical trial NCT04220801 · COMPLETED
Trial details
- NCT number
- NCT04220801
- Sponsor
- Shanghai Zhimeng Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2020-11-18
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.